WAKAMOTO PHARMACEUTICAL CO.,LTD. (4512)

Market cap
¥12.1B
P/E ratio
60.2x
Wakamoto Pharmaceutical manufactures branded drugs, generic medicines, and health products like Koryoku Wakamoto for healthcare providers and consumers in Japan and internationally.
Period EndNet income margin (%) YoY (%)
Mar 31, 20250.8-41.25%
Mar 31, 20241.4-11.80%
Mar 31, 20231.6-43.90%
Mar 31, 20222.8-142.06%
Mar 31, 2021-6.8-55.41%
Mar 31, 2020-15.2+798.99%
Mar 31, 2019-1.7-246.08%
Mar 31, 20181.2+32.08%
Mar 31, 20170.9+376.97%
Mar 31, 20160.2-76.37%
Mar 31, 20150.8-90.40%
Mar 31, 20148.1+343.08%
Mar 31, 20131.8-242.20%
Mar 31, 2012-1.3
AI Chat